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A B S T R A C T
Regularly, STR results obtained with different PCR ampliﬁcation kits are compared, for instance with old
cases, when revisiting cold cases or when addressing cross-border crimes. It is known that differences in
primer design for the same loci in different kits may give rise to null alleles or shifted alleles. In this study,
the genotyping results of 2085 Dutch male samples were compared for six autosomal STR kits
(Promega’s PowerPlex1 16, ESX-16 and ESI-17 Systems, Qiagen’s Investigator1 ESSplex Kit and Applied
Biosystems’ AmpFlSTR1 Identiﬁler and NGM PCR Ampliﬁcation Kits). A total of 19 discordant autosomal
genotyping results were obtained that were examined by sequence analysis using Roche-454 next
generation sequencing and/or Sanger sequencing. A further 25 discordances were found and sequenced
for the Amelogenin locus. The 24 samples showing the same primer binding site mutation at the
Amelogenin locus were subjected to X-STR analysis in order to assess whether they could share a
common origin, which appeared not to be the case. Based on the sequencing results, we set the ﬁnal
genotypes and determined the allele frequencies of 23 autosomal STRs for the Dutch reference database.
 2014 The Authors. Published by Elsevier Ireland Ltd. 
Contents lists available at ScienceDirect
Forensic Science International: Genetics
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / fs ig
Open access under the CC BY-NC-ND license.1. Introduction
After expanding the European Standard Set (ESS) of markers
used for autosomal forensic short tandem repeat (STR) genotyping
[1,2], a number of companies developed commercially available
kits incorporating these loci [3]. Examples of these kits are the
PowerPlex ESX and ESI Systems (Promega Corporation (Promega),
Madison, WI, USA), the Investigator ESSplex (Plus) Kit (Qiagen
Benelux B.V. (Qiagen), Venlo, The Netherlands) and the AmpFlSTR 
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Open access under the NGMTM (SElect) PCR Ampliﬁcation Kit (Applied Biosystems (AB),
Foster City, CA, USA). When comparing genotyping results of the
same donor obtained with different PCR ampliﬁcation kits,
differences such as null (a.k.a. silent) alleles and shifted alleles
have been observed, primarily due to differences in primer design
(e.g. [4–6]). With an increasing number of forensically available
kits and a growing number of (international) DNA proﬁle
comparisons worldwide, for instance under the European Pru¨m
Treaty, it is informative to know the extent of discordances at
speciﬁc loci. When certain discordances occur regularly, this
information may stimulate companies to include primer adjust-
ments, such as degenerated primers, in newly developed forensic
kits.
In this study, 2085 Dutch male samples were typed for six
autosomal STR kits: the PowerPlex1 16 (PP16), ESX-16 and ESI-17
Systems (Promega), the Investigator1 ESSplex Kit (ESS, Qiagen)
and the AmpFlSTR1 Identiﬁler and NGM PCR Ampliﬁcation Kits
(AB). We evaluated the concordancy of the genotyping results
obtained with these kits. Discordant allele calls were examined
using Roche-454 next generation sequencing (NGS) and/or Sanger
sequencing in order to identify the causal mutations. AdditionalCC BY-NC-ND license.
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24 donors having the same Amelogenin primer binding site
mutation could share a common origin. Based on the sequencing
results, the ﬁnal genotypes were set and used to create a new
Dutch allele frequency database.
2. Material and methods
2.1. DNA samples, extraction and quantiﬁcation
A total of 2085 male blood donors with self-declared Dutch
ancestry were sampled from 99 locations across The Netherlands,
while excluding major cities to avoid very recent admixture effects.
All volunteers had given their informed consent, and a detailed
description of the samples is given in [7]. After anonymising the
samples, DNA was robotically extracted either by the Autopure LS1
system using the Gentra Puregene Blood Kit (Gentra Systems,
Minneapolis, MN) or by the QIAcube using the QIAamp DNA Mini
Kit (Qiagen Benelux B.V. (Qiagen), Venlo, The Netherlands). The
samples were quantiﬁed with the Quantiﬁler1 Duo DNA Quantiﬁ-
cation Kit on a 7500 Real-Time PCR System (Applied Biosystems
(AB), Foster City, CA, USA).
2.2. PCR, capillary electrophoresis and DNA proﬁle analysis
DNA ampliﬁcations were performed using six different
autosomal STR kits: PP16, ESX-16 and ESI-17 (Promega), ESS
(Qiagen) and Identiﬁler and NGM (AB). PCR ampliﬁcation
programs were performed according to the manufacturer’s
protocols, except for the reaction volumes (Table 1). The PCR
input and reaction volume, the capillary electrophoresis instru-
ment, setup and settings, and the DNA proﬁle analysis software
and detection threshold are shown in Table 1 for the six different
STR kits.
2.3. Roche-454 next generation sequencing, Sanger sequencing
and X-STR analysis
Supplementary Text 1 describes the material and methods for
Roche-454 NGS, analysis of NGS data [8–10], Sanger sequencing
and X-STR analysis. Primers used during Sanger sequencing and X-
STR analysis are presented in Supplementary Table 1.
2.4. Concordancy testing, allele frequencies and
statistical analyses
The complete data set was tested for the presence of population
substructure as described in [7], and no substructure was detected
(data not shown). Therefore, the complete dataset was interpreted
as one group. The 2085 genotypes from all six kits were comparedTable 1
Characteristics of the PCR ampliﬁcation, capillary electrophoresis and DNA proﬁle anal
PCR Capillary electrophoresis 
Kit Input
(ng)
Reaction
volume (mL)
Instrument
ABI Prism1
ddH2O
(mL)
Hi-Di formamide
(mL)
Size st
PP16 1.5 12.5 3100 11.4 – 0.6 mL
ESX-16 1.5 7.5 3100 11.5 – 0.5 mL
ESI-17 0.5 12.5 3130xl – 10.0 1.0 mL
ESS 1.5 7.5 3100 11.5 – 0.5 mL
Identiﬁler 4.0 12.5 3100 11.6 – 0.4 mL
NGM 0.5 12.5 3130xl – 8.7 0.3 mL
a 30x diluted PCR product.using Excel and discordant allele calls were identiﬁed. After
sequencing analysis of discordant alleles, one ﬁnal database was
created comprising 2085 genotypes for 23 autosomal STRs and
Amelogenin. With this database, the allele frequencies and
descriptive statistics for this Dutch population sample were
determined using the Excel Microsatellite Toolkit [11].
3. Results and discussion
3.1. Discordances between six autosomal STR kits
The 2085 DNA samples were analysed with six autosomal STR
kits (PP16, ESX-16, ESI-17, ESS, Identiﬁler and NGM), comprising a
total of 23 different autosomal STR loci and Amelogenin (Fig. 1). The
genotyping results for the 20 STRs and Amelogenin that are present
in more than one kit (Penta D and E only reside in PP16, SE33 only
resides in ESI-17; see Fig. 1) were compared and 44 discordances
were detected in 38 DNA samples (Table 2). These discrepancies
comprise 43 null alleles on 12 loci and one shifted allele with a size
difference of one nucleotide (Table 2). Just when all 2085 samples
had been analysed with the NGM kit, Applied Biosystems adjusted
the kit (without changing the name; kit lot-numbers 1103010 M and
up) by adding extra primers for Amelogenin, D2S441 and D22S1045
that cover reported primer binding site mutations on these loci
[12,13]. All discordant samples were reanalysed with this new
version of NGM (here denoted NGM2), and the 24 missing X alleles
on Amelogenin and the absent allele 14.1 on D2S441 were now
detected and concordant with the results from other kits. As a result,
the ﬁnal number of discordant results decreased to 19, and these
discordances occurred in 13 of the 2085 samples (for six samples, the
same discordant result was seen in two different kits; Table 2). Seven
discordant alleles were found for Identiﬁler and NGM/NGM2, three
for ESI-17, and one for both PP16 and ESS (Table 2); ESX-16 showed
no discordant allele calls (Table 2).
3.2. Roche-454 NGS and/or Sanger sequencing of samples with
discordant results
In order to determine the genetic variations causing the above-
mentioned 44 discordant results, the loci involved were sequenced
for the affected samples and control samples. First, Roche-454 NGS
was applied using primers designed by Kline et al. [5], and when no
(clear) results were obtained, Sanger sequencing was used with
custom-designed primers both further away from the repeat than
those by Kline et al. [5] (Supplementary Table 1). For 42 of the 44
discordances a nucleotide change or nucleotide insertion or
deletion was observed that probably caused the discordant
genotyping result (Table 2 and Supplementary Data 1). For two
samples, with a null allele at D12S391 for the ESI-17 and NGM/
NGM2 kits, the discordant allele could not be ampliﬁed and noysis for the six autosomal PCR kits analysed in this study.
DNA proﬁle analysis
andard Sample Settings Software Detection
threshold (rfu)
 ILS 600 1.0 mL 3 kV/11 s GeneMarker v. 1.75 30
 ILS 500 1.0 mLa 3 kV/5 s GeneMarker v. 1.75 30
 CC5 ILS 500 1.0 mL 1.5 kV/10 s GeneMapper ID-X v.1.1.1 50
 DSS 550 1.0 mL 3 kV/10 s GeneMarker v. 1.75 30
 LIZ 600 1.0 mL 1 kV/22 s GeneMarker v. 1.75 30
 LIZ 500 1.0 mL 3 kV/15 s GeneMapper ID-X v.1.1.1 50
Fig. 1. Fragment lengths for 23 autosomal STR markers and Amelogenin and their presence in six forensic STR kits: PP16, ESX-16 and ESI-17 (Promega, grey shades), ESS
(Qiagen, red shade), Identiﬁler and NGM (Applied Biosystems, blue shades). Amplicon sizes are based on the shortest and longest fragment length in the allelic ladder for each
marker. When a kit name is presented in grey, the marker is not present in the kit.
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between the occurrence of the null allele and the location of the
various primers: kits that do detect the allele have reverse primers
close to the repeat structure (for ESX the reverse primer starts 30 nt
and for ESS 43 nt after the repeat; Supplementary Data 1), while
the kits and custom-designed primers that do not reveal the allele
have reverse primers further on (primer start for NGM is at
position 125 (Supplementary Data 1) and for the various
sequencing primers at nucleotide 213 [5], 271 or 345). We infer
that both null alleles are caused by a deletion of at least a few
hundred nucleotides, residing after the position of the ESS reverse
primer and covering the binding sites of the sequencing primers
and the reverse primers in NGM/NGM2 and ESI-17 (for this kit, the
exact primer start is unknown).
Many studies have been conducted to determine the
molecular basis of discordant results (e.g. [5,14–17]). When null
alleles are observed relatively often (for instance in speciﬁc
populations [16,18,19]) and are due to a primer binding site
mutation, manufacturers may add degenerate primers to thecommercially available STR kits in order to recover the speciﬁc
allele [13,18,19]. The majority of discordant results, however, are
rare, like most of the discordances found in our study. Despite
their rarity, at least three of the autosomal discordances that we
detected have been described before: 1) a G>A substitution
172 bp after the D18S51 repeat motif, described as position
75615 in GenBank sequence AC021803 by Delamoye et al. [15],
and Vanderheyden et al. [17], 2) a C>T substitution 81 bp before
the repeat structure of TH01, which was described by Li et al.
[20], and 3) an A>T substitution 52 bp before the repeat motif of
vWA, described as position 1631 in GenBank sequence M25858
by Alves et al. [21], Delamoye et al. [15], Vanderheyden et al. [17],
and Kline et al. [5].
Except for Amelogenin, the markers that are present in both
Identiﬁler and NGM are said to have the same primer binding
positions [12]. Notwithstanding, null alleles were detected for
D2S1338 and D16S539 for Identiﬁler that were not observed for
NGM (Table 2). We think the prolonged annealing time in the NGM
protocol (3 min versus 1 min) made it possible to detect these
Table 2
Discordancy between six autosomal STR kits: PP16, ESX-16, ESI-17, ESS, Identiﬁler and NGM, based on 2085 Dutch male donor samples. Discordant results are shown in grey.
Marker Discordancy Promega Qiagen AB n observations Sequencing
method
Putative cause
PP16 ESX-16 ESI-17 ESS Identiﬁler NGM NGM2a 5 kits +
NGM
5 kits +
NGM2
Mutation position before/
after repeatc
Location in primerd
Amel. null allele X XY XY XY XY XY Y XY 24 0 454 A: 44 C>T 21 nt after start NGM R-primer
Amel. null allele Y XY XY XY XY XY X as NGM 1 1 454/Sanger A: 51 G>A 14 nt after start NGM R-primer
D2S1338 null allele 17 – 17–20 17–20 17–20 20 17–20 as NGM 1 1 Sanger A: 174 G>A 23 nt after start Identiﬁler R-primer
D2S441 null allele 14.1 – 11–14.1 11–14.1 11–14.1 – 11 11–14.1 1 0 454 B: 1 insA 23 nt after start NGM F-primer
D7S820 null allele 12 12–13 – – – 13 – – 1 1 454 A: 125 C>A start Identiﬁler R-primer unknown
D8S1179 null allele 12.1 12.1–13 12.1–13 13 12.1–13 12.1–13 12.1–13 as NGM 1 1 454 insT ﬁnal repeat [TCTTA] start ESI-17 R-primer unknown
D12S391 null allele 21 – 18–21 18 18–21 – 18 as NGM 2b 2b 454/Sanger large del involving
NGM, ESI-17, Kline [5]
and 2 custom-madee
R-primers
D12S391 null allele 21 – 21–22 22 21–22 – 22 as NGM 2b 2b 454/Sanger large del involving NGM,
ESI-17, Kline [5] and
2 custom-madee R-primers
D13S317 null allele 8 11 – – – 8–11 – – 1 1 454 A: 27 C>A 18 nt after start PP16 R-primer
D16S539 null allele 13 12–13 12–13 12–13 12–13 12 12–13 as NGM 1 1 454 B: 140 G>A 17 nt after start Identiﬁler F-primer
D18S51 null allele 16 15–16 15–16 15–16 15–16 15 15 as NGM 2b 2b 454 A: 172 G>A 8 nt after start
Identiﬁler + NGM R-primer
D19S433 allele shift
14 to 13.3
– 14–15 14–15 13.3–15 14–15 14–15 as NGM 1 1 454 B: 50 delA in between ESS and other
(known) F-primers
TH01 null allele 6 6–9 6–9 6–9 6–9 9 9 as NGM 2b 2b 454 B: 81 C>T 14 nt after start Identiﬁler + NGM F-primer
vWA null allele 17 17–19 17–19 17–19 17–19 19 19 as NGM 2b 2b 454 B: 52 A>T 19 nt after start Identiﬁler + NGM F-primer
vWA null allele 17 16–17 16–17 16–17 16–17 16 16 as NGM 2b 2b 454 B: 52 A>T 19 nt after start Identiﬁler + NGM F-primer
Total 1 0 3 1 7 32 7 44 19
a NGM2 is only tested on the discordant samples.
b Both observations involve the same donor and the discordancy was seen in two different kits.
c Mutation position before (B) or after (A) the repeat, and in the direction as given in STRbase (accessed October 2013); see also Supplementary Data 1.
d For most primers, the (start) position is given in Supplementary Data 1.
e Up to 345 nt from repeat.
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other allele in the heterozygous allele set (peak height ratios were
0.06 and 0.13, respectively).
All 24 samples that showed a null allele for X on Amelogenin
when typed with NGM have the same G>A substitution (Table 2
and Supplementary Data 1). Green et al. [13] described that the
discovery of rare population-speciﬁc variant alleles for AMEL
prompted the adjustment of the AMEL primers, which was put
into effect in the summer of 2011. The use of this updated NGM kit
(here denoted NGM2), resolved all AMELX null alleles in our
samples, indicating that this mutation is not very rare in the Dutch
dataset as it occurs with a frequency of 1.15%. Interestingly, none
of the other reported AMELX null alleles [22–26], with estimated
frequencies up to 2% in speciﬁc populations, were found in our
dataset. In order to analyse whether the Dutch male donors of
these samples could share a common origin, we tested X-STRs in
all these Amelogenin mutation carriers. A homemade multiplex
was used that contains the SRY male gender marker and 13 X-STRs
of all four linkage groups [27,28]. Three of the markers in this
multiplex (DXS8378, DXS9902 and DXS6807) reside in the same
area of the X-chromosome as Amelogenin, but no apparent
similarities at these three loci were seen among the 24 samples
(results not shown). Thus, no apparent association between the X-
STR results and the G>A substitution in the Amelogenin gene
could be made. This suggests there is no recent common origin for
this mutation in our study population.
3.3. Number and percentage discordant and concordant results
A consolidated database (denoted 2085-database) comprising
2085 genotypes of 23 autosomal STR loci and Amelogenin was
created. For the samples that showed a null allele, the detected
allele was included in the database. For the sample with the shiftedTable 3
Number and percentage of discordant results on genotype and allele level obtained wi
Present in # kits n samples n analysed 
Genotype 
Amelogenin 6 2085 12,510 
D16S539 6 2085 12,510 
D18S51 6 2085 12,510 
D21S11 6 2085 12,510 
D3S1358 6 2085 12,510 
D8S1179 6 2085 12,510 
FGA 6 2085 12,510 
TH01 6 2085 12,510 
VWA 6 2085 12,510 
D19S433 5 2085 10,425 
D2S1338 5 2085 10,425 
D10S1248 4 2085 8340 
D12S391 4 2085 8340 
D1S1656 4 2085 8340 
D22S1045 4 2085 8340 
D2S441 4 2085 8340 
CSF1PO 2 2085 4170 
D13S317 2 2085 4170 
D5S818 2 2085 4170 
D7S820 2 2085 4170 
TPOX 2 2085 4170 
PENTA D 1 2085 2085 
PENTA E 1 2085 2085 
SE33 1 2085 2085 
Total n.a.a 50,040 20,2245 
a Not applicable.allele in ESS for D19S433, we included the allele call presented by
the other four kits, as the deleted nucleotide was found in the
ﬂanking regions of the repeat (Table 2 and Supplementary Data 1).
Next, we determined the number and percentage of discordant
genotypes and alleles for each locus (Table 3). The highest
percentage of discordant results was found for locus D12S391
(genotypes: 0.048% and alleles: 0.024%), which was typed by four
different kits. Fully concordant results for all kits tested were
obtained for 9 loci typed with 2 to 6 kits. For three loci (Penta D,
Penta E and SE33) no comparisons could be made, as they were
only present in one of the tested kits. Overall, 99.991% of the
genotypes and 99.995% of the alleles show fully concordant results
for our Dutch reference dataset of 2085 samples.
3.4. Allele frequencies and descriptive statistics
The frequencies in the new Dutch allele frequency database are
given in Table 4. Compared to the former Dutch database [29],
which was based on 231 samples for the SGM Plus (AB) and 201 for
the Proﬁler (AB) loci, 52 new alleles were detected that had
between one and thirteen occurrences in the 2085-dataset. One
allele that was detected once in the former database was not
revealed in the 2085-dataset. The largest difference between the
allele frequencies of the former and the new database is 0.048. In
the new allele frequency database 97 of the 361 different alleles
have frequencies below 0.001 ( four occurrences) of which 48
alleles occur only once.
The summary statistics together with the heterozygosity and
PIC values are shown in Supplementary Table 2. SE33 shows the
highest heterozygosity and PIC values, which can be explained by
the high number of microvariants resulting in 59 different alleles
(Table 4) detected for this locus compared to the average of 15.65
different alleles per marker.th six autosomal STR kits.
n discordances % discordances
Allele Genotype Allele Genotype Allele
25,020 1 1 0.008 0.004
25,020 1 1 0.008 0.004
25,020 2 2 0.016 0.008
25,020 0 0 0.000 0.000
25,020 0 0 0.000 0.000
25,020 1 1 0.008 0.004
25,020 0 0 0.000 0.000
25,020 2 2 0.016 0.008
25,020 4 4 0.032 0.016
20,850 1 1 0.010 0.005
20,850 1 1 0.010 0.005
16,680 0 0 0.000 0.000
16,680 4 4 0.048 0.024
16,680 0 0 0.000 0.000
16,680 0 0 0.000 0.000
16,680 0 0 0.000 0.000
8340 0 0 0.000 0.000
8340 1 1 0.024 0.012
8340 0 0 0.000 0.000
8340 1 1 0.024 0.012
8340 0 0 0.000 0.000
4170 n.a. n.a. n.a. n.a.
4170 n.a. n.a. n.a. n.a.
4170 n.a. n.a. n.a. n.a.
40,4490 19 19 0.009 0.005
Table 4
Overview of the number and frequency of alleles per marker.
Allele Count Frequency
D1S1656
10 7 0.00168
11 312 0.07482
12 517 0.12398
13 239 0.05731
14 365 0.08753
14.3 7 0.00168
15 547 0.13118
15.3 312 0.07482
16 495 0.11871
16.1 1 0.00024
16.3 229 0.05492
17 241 0.05779
17.1 3 0.00072
17.3 592 0.14197
18 16 0.00384
18.3 224 0.05372
19 2 0.00048
19.3 57 0.01367
20.3 4 0.00096
D2S441
8 2 0.00048
9 1 0.00024
10 787 0.18873
11 1431 0.34317
11.3 177 0.04245
12 198 0.04748
12.3 7 0.00168
13 107 0.02566
13.3 2 0.00048
14 1225 0.29376
14.1 1 0.00024
15 207 0.04964
16 25 0.00600
D2S1338
12 1 0.00024
14 1 0.00024
15 2 0.00048
16 159 0.03813
17 809 0.19400
18 349 0.08369
19 486 0.11655
20 632 0.15156
21 127 0.03046
22 131 0.03141
23 391 0.09376
24 512 0.12278
25 469 0.11247
26 90 0.02158
27 7 0.00168
28 4 0.00096
D3S1358
10 1 0.00024
11 8 0.00192
13 25 0.00600
14 512 0.12278
15 1028 0.24652
16 1008 0.24173
17 902 0.21631
18 644 0.15444
19 39 0.00935
20 3 0.00072
D5S818
7 2 0.00048
8 15 0.00360
9 127 0.03046
10 211 0.05060
11 1468 0.35204
12 1571 0.37674
13 729 0.17482
14 40 0.00959
15 6 0.00144
16 1 0.00024
Table 4 (Continued )
Allele Count Frequency
D7S820
7 80 0.01918
8 690 0.16547
9 750 0.17986
10 1081 0.25923
10.3 1 0.00024
11 803 0.19257
11.3 1 0.00024
12 533 0.12782
13 190 0.04556
14 38 0.00911
15 3 0.00072
D8S1179
8 80 0.01918
9 70 0.01679
10 371 0.08897
11 323 0.07746
12 665 0.15947
12.1 1 0.00024
13 1333 0.31966
14 813 0.19496
15 383 0.09185
16 110 0.02638
17 21 0.00504
D10S1248
7 1 0.00024
10 3 0.00072
11 11 0.00264
12 148 0.03549
13 1318 0.31607
14 1281 0.30719
15 819 0.19640
16 489 0.11727
17 85 0.02038
18 14 0.00336
19 1 0.00024
D12S391
14 1 0.00024
15 173 0.04149
16 156 0.03741
16.3 1 0.00024
17 419 0.10048
17.3 95 0.02278
18 732 0.17554
18.3 92 0.02206
19 430 0.10312
19.3 41 0.00983
20 503 0.12062
20.2 1 0.00024
20.3 2 0.00048
21 546 0.13094
22 423 0.10144
23 313 0.07506
24 154 0.03693
25 65 0.01559
26 15 0.00360
27 6 0.00144
28 1 0.00024
29 1 0.00024
D13S317
7 6 0.00144
8 458 0.10983
9 309 0.07410
10 275 0.06595
11 1236 0.29640
12 1225 0.29376
13 468 0.11223
14 190 0.04556
15 3 0.00072
D16S539
7 1 0.00024
8 70 0.01679
9 540 0.12950
10 272 0.06523
A.A. Westen et al. / Forensic Science International: Genetics 10 (2014) 55–6360
Table 4 (Continued )
Allele Count Frequency
11 1341 0.32158
12 1102 0.26427
13 748 0.17938
14 94 0.02254
15 1 0.00024
16 1 0.00024
D18S51
9 4 0.00096
10 33 0.00791
11 58 0.01391
12 655 0.15707
13 575 0.13789
14 687 0.16475
15 596 0.14293
16 514 0.12326
17 448 0.10743
18 299 0.07170
19 153 0.03669
20 82 0.01966
21 38 0.00911
22 18 0.00432
23 4 0.00096
24 6 0.00144
D19S433
10 2 0.00048
11 21 0.00504
12 279 0.06691
12.1 4 0.00096
12.2 1 0.00024
13 890 0.21343
13.2 76 0.01823
14 1527 0.36619
14.2 97 0.02326
15 763 0.18297
15.2 176 0.04221
16 222 0.05324
16.2 70 0.01679
17 22 0.00528
17.2 14 0.00336
18 1 0.00024
18.2 4 0.00096
19.2 1 0.00024
D21S11
24.2 1 0.00024
25.2 1 0.00024
26 7 0.00168
27 179 0.04293
28 706 0.16930
28.2 1 0.00024
29 839 0.20120
29.2 3 0.00072
29.3 2 0.00048
30 1079 0.25875
30.2 137 0.03285
31 382 0.09161
31.2 325 0.07794
32 67 0.01607
32.2 306 0.07338
33 12 0.00288
33.2 109 0.02614
34 1 0.00024
34.1 2 0.00048
34.2 8 0.00192
35 2 0.00048
35.2 1 0.00024
D22S1045
10 6 0.00144
11 586 0.14053
12 56 0.01343
13 25 0.00600
14 212 0.05084
15 1356 0.32518
16 1546 0.37074
17 351 0.08417
18 28 0.00671
Table 4 (Continued )
Allele Count Frequency
19 4 0.00096
CSF1PO
6 1 0.00024
7 5 0.00120
8 10 0.00240
9 94 0.02254
10 1063 0.25492
10.3 1 0.00024
11 1280 0.30695
12 1389 0.33309
13 267 0.06403
14 52 0.01247
15 7 0.00168
16 1 0.00024
FGA
17 5 0.00120
18 75 0.01799
19 253 0.06067
19.1 2 0.00048
19.2 4 0.00096
20 559 0.13405
20.2 1 0.00024
21 696 0.16691
21.2 13 0.00312
22 718 0.17218
22.1 1 0.00024
22.2 31 0.00743
23 614 0.14724
23.2 14 0.00336
24 574 0.13765
24.2 5 0.00120
25 428 0.10264
26 156 0.03741
27 20 0.00480
28 1 0.00024
VWA
10 1 0.00024
12 2 0.00048
13 8 0.00192
14 412 0.09880
15 407 0.09760
16 859 0.20600
17 1143 0.27410
18 833 0.19976
19 442 0.10600
20 60 0.01439
21 3 0.00072
PENTA D
2.2 1 0.00024
5 3 0.00072
6 2 0.00048
7 28 0.00671
8 85 0.02038
9 870 0.20863
10 413 0.09904
11 568 0.13621
12 968 0.23213
13 885 0.21223
13.4 5 0.00120
14 283 0.06787
14.1 3 0.00072
15 41 0.00983
16 13 0.00312
17 1 0.00024
18 1 0.00024
PENTA E
5 298 0.07146
6 10 0.00240
7 712 0.17074
8 43 0.01031
9 44 0.01055
10 367 0.08801
11 398 0.09544
12 825 0.19784
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Table 4 (Continued )
Allele Count Frequency
13 391 0.09376
14 256 0.06139
15 210 0.05036
16 218 0.05228
17 205 0.04916
18 101 0.02422
19 44 0.01055
20 31 0.00743
21 12 0.00288
22 3 0.00072
23 2 0.00048
TH01
5 30 0.00719
6 875 0.20983
7 754 0.18082
8 463 0.11103
8.3 1 0.00024
9 564 0.13525
9.3 1445 0.34652
10 38 0.00911
TPOX
7 2 0.00048
8 2258 0.54149
9 395 0.09472
10 239 0.05731
11 1077 0.25827
12 193 0.04628
13 6 0.00144
SE33
10.2 1 0.00024
11 2 0.00048
11.2 2 0.00048
12 19 0.00456
12.2 1 0.00024
13 32 0.00767
13.2 7 0.00168
13.3 2 0.00048
14 112 0.02686
14.2 6 0.00144
14.3 1 0.00024
15 147 0.03525
15.2 2 0.00048
15.3 5 0.00120
16 182 0.04365
16.2 1 0.00024
16.3 4 0.00096
17 265 0.06355
17.2 1 0.00024
17.3 4 0.00096
18 280 0.06715
18.2 3 0.00072
18.3 4 0.00096
19 261 0.06259
19.1 2 0.00048
19.2 22 0.00528
20 202 0.04844
20.1 2 0.00048
20.2 65 0.01559
20.3 1 0.00024
21 134 0.03213
21.2 74 0.01775
22 36 0.00863
22.2 119 0.02854
23 11 0.00264
23.2 113 0.02710
24 3 0.00072
24.2 134 0.03213
25.2 149 0.03573
25.3 4 0.00096
26.2 265 0.06355
27 2 0.00048
27.2 355 0.08513
27.3 1 0.00024
28.2 347 0.08321
29.2 301 0.07218
Table 4 (Continued )
Allele Count Frequency
30.2 236 0.05659
31 1 0.00024
31.2 111 0.02662
32 8 0.00192
32.2 46 0.01103
33 40 0.00959
33.2 19 0.00456
34 10 0.00240
34.2 3 0.00072
35 5 0.00120
35.2 2 0.00048
36 2 0.00048
37 1 0.00024
A.A. Westen et al. / Forensic Science International: Genetics 10 (2014) 55–63624. Concluding remarks
Nineteen discordant alleles were detected in 2085 Dutch male
donor samples that were analysed for six autosomal STR kits (giving
99.995% concordant alleles overall). The numbers of null or shifted
alleles vary for the different commercial kits: seven in Identiﬁler,
seven in NGM2, three in ESI-17, one in PP16, one in ESS and none in
ESX-16. Upon Roche-454 and/or Sanger sequencing nucleotide
changes, insertions and deletions (single nucleotide or stretches of at
least few hundred nucleotides) were found that could account for
the discordant genotypes. The use of as much as 2085 samples
generated a highly detailed allele frequency database, which can be
of assistance in evidentiary value calculations.
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